6092 — Enbio Holdings Cashflow Statement
0.000.00%
Annual cashflow statement for Enbio Holdings, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Tanshin |
| Standards: | JAS | JAS | JAS | JAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 1,099 | 1,233 | 1,066 | 702 | 915 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 98.5 | 127 | -298 | 79.7 | 697 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 873 | 229 | 506 | -1,258 | -988 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 2,413 | 1,989 | 1,712 | 22.4 | 1,167 |
| Capital Expenditures | -1,165 | -1,165 | -1,079 | -1,467 | -1,053 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -316 | -605 | -505 | -136 | 158 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1,481 | -1,770 | -1,584 | -1,603 | -895 |
| Financing Cash Flow Items | -86.4 | -22.2 | -50.8 | -70.1 | -21 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -535 | 241 | 639 | 1,274 | 464 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 356 | 457 | 775 | -311 | 744 |